Glucotrack, Inc. Files 8-K
Ticker: GCTK · Form: 8-K · Filed: Oct 1, 2024 · CIK: 1506983
Sentiment: neutral
Topics: reporting, sec-filing
TL;DR
Glucotrack filed an 8-K, standard reporting, no new info.
AI Summary
Glucotrack, Inc. filed an 8-K on October 1, 2024, to report a Regulation FD Disclosure and Financial Statements and Exhibits. The filing does not contain specific financial figures or material events beyond the standard reporting requirements.
Why It Matters
This 8-K filing indicates Glucotrack, Inc. is meeting its reporting obligations with the SEC, but it does not disclose any new material information that would immediately impact its stock.
Risk Assessment
Risk Level: low — The filing is a routine 8-K for reporting purposes and does not contain any new material information or events that would suggest increased risk.
Key Players & Entities
- Glucotrack, Inc. (company) — Registrant
- 001-41141 (company) — SEC File Number
- 98-0668934 (company) — IRS Employer Identification No.
- October 1, 2024 (date) — Date of earliest event reported
FAQ
What is the primary purpose of this 8-K filing for Glucotrack, Inc.?
The primary purpose of this 8-K filing is to report a Regulation FD Disclosure and to file Financial Statements and Exhibits, as indicated in the filing details.
When was the earliest event reported in this 8-K filing?
The earliest event reported in this 8-K filing was on October 1, 2024.
What is Glucotrack, Inc.'s state of incorporation?
Glucotrack, Inc. is incorporated in Delaware.
What is Glucotrack, Inc.'s principal executive office address?
Glucotrack, Inc.'s principal executive offices are located at 301 Rte 17 North, Ste. 800, Rutherford, NJ 07070.
Does this 8-K filing disclose any specific financial results or material events?
Based on the provided text, this 8-K filing is primarily for reporting purposes (Regulation FD Disclosure, Financial Statements and Exhibits) and does not explicitly detail specific financial results or new material events.
Filing Stats: 483 words · 2 min read · ~2 pages · Grade level 11 · Accepted 2024-10-01 09:15:11
Filing Documents
- form8-k.htm (8-K) — 40KB
- ex99-1.htm (EX-99.1) — 15KB
- ex99-1_001.jpg (GRAPHIC) — 55KB
- 0001493152-24-038952.txt ( ) — 306KB
- gctk-20241001.xsd (EX-101.SCH) — 3KB
- gctk-20241001_lab.xml (EX-101.LAB) — 33KB
- gctk-20241001_pre.xml (EX-101.PRE) — 24KB
- form8-k_htm.xml (XML) — 4KB
SIGNATURES
SIGNATURES Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized. Date: October 1, 2024 GLUCOTRACK, INC. By: /s/ Paul Goode Name: Paul Goode Title: Chief Executive Officer